Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy of BNC210 in Acute, As-needed Treatment of Anxiety in Social Anxiety Disorder - 1
Sponsor: Bionomics Limited
Summary
The purpose of the study is to evaluate the effect of a single, acute dose of BNC210 compared to placebo on reducing the severity of anxiety provoked by a behavioral assessment task and measured using the Subjective Units of Distress Scale (SUDS) in adult patients with social anxiety disorder.
Official title: A Phase 3, Randomized, Double-blind, 2-arm, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of BNC210 for the Acute, As-needed Treatment of Anxiety in Adults With Social Anxiety Disorder
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
370
Start Date
2024-08-06
Completion Date
2025-09-19
Last Updated
2026-05-19
Healthy Volunteers
No
Conditions
Interventions
225 mg BNC210
225 mg BNC210
Placebo
Placebo
Locations (21)
AFFIRM-1 Study Site
Encino, California, United States
AFFIRM-1 Study Site
La Jolla, California, United States
AFFIRM-1 Study Site
Los Angeles, California, United States
AFFIRM-1 Study Site
Oceanside, California, United States
AFFIRM-1 Study Site
San Diego, California, United States
AFFIRM-1 Study Site
San Jose, California, United States
AFFIRM-1 Study Site
Sherman Oaks, California, United States
AFFIRM-1 Study Site
Temecula, California, United States
AFFIRM-1 Study Site
Jacksonville, Florida, United States
AFFIRM-1 Study Site
Lauderhill, Florida, United States
AFFIRM-1 Study Site
Miami Lakes, Florida, United States
AFFIRM-1 Study Site
Orlando, Florida, United States
AFFIRM-1 Study Site
Tampa, Florida, United States
AFFIRM-1 Study Site
Decatur, Georgia, United States
AFFIRM-1 Study Site
Boston, Massachusetts, United States
AFFIRM-1 Study Site
Boston, Massachusetts, United States
AFFIRM-1 Study Site
Princeton, New Jersey, United States
AFFIRM-1 Study Site
Brooklyn, New York, United States
AFFIRM-1 Study Site
Charlotte, North Carolina, United States
AFFIRM-1 Study Site
Media, Pennsylvania, United States
AFFIRM-1 Study Site
Austin, Texas, United States